$199.00 – $449.00Price range: $199.00 through $449.00
Initial charge of $39 for consult, price of medication(s) charged upon consult approval.
Dual-action GLP-1/GIP therapy designed to support metabolic health and long-term vitality. Personalized dosing and clinical guidance help align treatment with your wellness goals.
Compounded Tirzepatide with B12 is a prescription-only medication used to support healthy weight management and metabolic function. Starting at $239, this dual-action GLP-1/GIP therapy is designed to support metabolic health and long-term vitality with personalized dosing and clinical guidance to align treatment with your wellness goals. Tirzepatide is a dual GIP and GLP-1 receptor agonist that works by enhancing satiety, slowing gastric emptying, and improving insulin sensitivity. The addition of B12 helps support energy metabolism and reduce fatigue during weight loss. Important Note: Compounded medications are prepared by licensed U.S. compounding pharmacies and are not reviewed or approved by the FDA. Your Pentavia provider will determine if compounded tirzepatide with B12 is appropriate for your individual needs based on clinical evaluation.
This medication combines dual-action metabolic support: Tirzepatide (Dual GIP and GLP-1 receptor agonist):
This treatment offers unique advantages for metabolic wellness:
Use this chart as a general reference for eligibility: BMI Am I Eligible? * ≤ 24.9 Not eligible 25.0–26.9 Case-by-case** 27.0–29.9 Likely eligible** 30.0+ Likely eligible** *Final eligibility is determined by a Pentavia provider after a complete clinical evaluation. And other factors such as insulin resistance, prediabetes, or related metabolic health concerns may influence eligibility.
Simple administration for optimal results:
Complete Treatment Package
How is compounded tirzepatide with B12 different from other options?
Compounded tirzepatide with B12 is prepared through licensed U.S. pharmacies for individuals seeking clinician-guided metabolic support and personalized care plans.
Is compounded tirzepatide with B12 FDA-approved?
No. Compounded medications are not reviewed or approved by the FDA. They are prepared by licensed compounding pharmacies under strict provider supervision.
Is it safe for long-term use?
All prescriptions dispensed through Pentavia are monitored by licensed providers and sourced from FDA-registered compounding pharmacies.
When might I notice changes
Individual experiences vary. Your provider will monitor your progress and adjust your care plan as needed based on your personalized health goals.
Can I transition to an FDA-approved product later?
Your provider will discuss future options with you should FDA-approved therapies become available and fit your evolving treatment plan.
Do Not Use This Medication If You:
Compounded drugs are not reviewed or approved by the FDA and do not undergo FDA evaluation for safety or effectiveness. Pentavia’s compounded tirzepatide is prepared using tirzepatide base by FDA-registered, U.S.-licensed 503A compounding pharmacies. Product availability may vary based on state regulations and pharmacy partner. Pentavia does not practice medicine or provide medical care. All prescriptions and clinical decisions are made independently by licensed healthcare providers. Images are for illustrative purposes only; actual product packaging and appearance may vary.
